Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Role of HLA in hematopoietic SCT

Bone Marrow Transplantation volume 42, pages S71–S76 (2008)Cite this article

Abstract

HLA disparity between hematopoietic stem cell (HSC) donor and recipient triggers T-cell and NK-cell allorecognition, and induces the GVHD, GVL effect and/or may cause an engraftment failure. This review will cover the scope of human genomic variation, the methods of HLA typing and interpretation of high-resolution HLA results. We describe the main subsets of related and unrelated HSC donors and outline the main aspects of HLA disparity and their effect on the outcome of the patients after allogeneic HSC transplantation (HSCT). The HLA match between HSCT donor and recipient is crucial, but for many patients a perfectly matched donor is not available. The HSCT from the alternative mismatched donor with one allele/antigen mismatch (9/10) can be as beneficial as a HSCT from a fully matched donor, especially in younger patients. For the remaining patients, the donors with permissive mismatches may be the option. The permissiveness depends not only on the potential adverse effect of the HLA mismatches, but also on the urgency of the transplantation, the desirable GVL effect and the potential efficacy of the alternative therapy available for the patient.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Mullally A, Ritz J . Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007; 109: 1355–1362.

    Article  CAS  Google Scholar 

  2. http://bioinformatics.nmdp.org/HLA/Allele_Codes/DNA_Type_Lookup/dnatyp.pl?dna=.

  3. Cano P, Klitz W, Mack SJ, Maiers M, Marsh SGE, Noreen H et al. Common and well-documented HLA alleles. Report of the Ad-Hoc Committee of the American Society for Histocompatiblity and Immunogenetics. Hum Immunol 2007; 68: 392–417.

    Article  CAS  Google Scholar 

  4. Tiercy JM, Nicoloso G, Passweg J, Schanz U, Seger R, Chalandon Y et al. The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable. Bone Marrow Transplant 2007; 40: 515–522.

    Article  CAS  Google Scholar 

  5. Nowak J, Graczyk-Pol E, Mika-Witkowska R, Zajko M, Rogatko-Koros M, Sak-Budzisz J . Efficacy of bone marrow donor searches performed by Institute of Haematology and Transfusion Medicine in domestic and foreign registries in 1999–2006 for the patients with acute and chronic leukemia. Postepy Nauk Med 2007; 20: 298–303 (Eng. abstract).

    Google Scholar 

  6. Cohen BA, Mitra RD, Hughes JD, Church GM . A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression. Nat Genet 2000; 26: 183–186.

    Article  CAS  Google Scholar 

  7. Godder KT, Henslee-Downey PJ, Mehta J, Park B, Chiang K-Y, Abhyankar S et al. Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant 2007; 39: 751–757.

    Article  CAS  Google Scholar 

  8. Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski J et al. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 40: 1055–1062.

    Article  CAS  Google Scholar 

  9. Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR . Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 2007; 40: 63–70.

    Article  CAS  Google Scholar 

  10. Özdemir E, Saliba RM, Champlin RE, Couriel DR, Giralt SA, de Lima M et al. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplant 2007; 40: 125–136.

    Article  Google Scholar 

  11. Cheuk DKL, Wang P, Lee TL, Chiang AKS, Ha SY, Lau YL et al. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 935–944.

    Article  CAS  Google Scholar 

  12. Myers GD, Bollard CM, Wu M-F, Weiss H, Rooney CM, Heslop HE et al. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 677–686.

    Article  CAS  Google Scholar 

  13. Viollier R, Socié G, Tichelli A, Bacigalupo A, Korthof E, Marsh J et al. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 2008; 41: 45–50.

    Article  CAS  Google Scholar 

  14. Vicente D, Lamparelli T, Gualandi F, Occhini D, Raiola AM, Ibatici A et al. Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant. Bone Marrow Transplant 2007; 40: 349–354.

    Article  CAS  Google Scholar 

  15. Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen–identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 2006; 24: 5695–5702.

    Article  Google Scholar 

  16. Petersdorf EW, Gooley T, Malkki M, Horowitz M . Impact of donor–recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. In: Hansen JA (eds). Immunobiology of the human MHC (Proceedings of the 13th International Histocompatibility Workshop and Conference). IHWG Press: Seattle (in press).

  17. Sedlacek P, Formankova R, Mejstrikova E, Keslova P, Hubacek P, Dobrovolna M et al. Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen-mismatched unrelated donors. Pediatr Transplantation 2008; 12: 24–31.

    Article  Google Scholar 

  18. Greinix HT, Fae I, Schneider B, Rosenmayr A, Mitterschiffthaler A, Pelzmann B et al. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant 2005; 35: 57–62.

    Article  CAS  Google Scholar 

  19. Liao C, Wu JY, Xu ZP, Li Y, Yang X, Chen JS et al. Indiscernible benefit of high-resolution HLA typing in improving long-term clinical outcome of unrelated umbilical cord blood transplant. Bone Marrow Transplant 2007; 40: 201–208.

    Article  CAS  Google Scholar 

  20. Heemskerk MBA, Cornelissen JJ, Roelen DL, van Rood JJ, Claas FHJ, Doxiadis IIN et al. Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 193–200.

    Article  CAS  Google Scholar 

  21. Bornhäuser M, Schwerdtfeger R, Martin H, Frank C, Theuser C, Ehninger G . Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood 2004; 103: 2860–2861.

    Article  Google Scholar 

  22. Lowe EJ, Turner V, Handgretinger R, Horwitz EM, Benaim E, Hale GA et al. T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation. British Journal of Haematology 2003; 123: 323–326.

    Article  Google Scholar 

  23. Ottinger HD, Beelen DW, Peceny R, Elmaagacli AH, Grosse-Wilde H . Change of paradigm in donor selection for hematopoietic stem cell transpiantation: for patients above 40 years with early stage leukaemia HLA-identical siblings are no longer first choice. Bone Marrow Transplant 2004; 33 (Suppl 1): S68 (abstr. O376).

    Google Scholar 

  24. Finke J, Schmoor C, Lang H, Potthoff K, Bertz H . Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. J Clin Oncol 2003; 21: 506–513.

    Article  Google Scholar 

  25. Morishima Y, Kawase T, Malkki M, Petersdorf EW . Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. Tissue Antigens 2007; 69 (Suppl 1): 31–35.

    Article  Google Scholar 

  26. Hurley CK, Fernandez-Vina M, Hildebrand WH, Noreen HJ, Trachtenberg E, Williams TM et al. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor–recipient pairs. Hum Immunol 2007; 68: 30–40.

    Article  CAS  Google Scholar 

  27. Nowak J, Kalinka-Warzocha E, Juszczyñski P, Mika-Witkowska R, Zajko M, Graczyk-Pol E et al. Haplotype-specific pattern of association of human MHC with non-Hodgkin's lymphoma outcome. Tissue Antigens 2008; 71: 16–26.

    Article  CAS  Google Scholar 

  28. Middleton D, Menchaca L, Rood H, Komerofsky R . New allele frequency database:. www.allelefrequencies.net. Tissue Antigens 2003; 61: 403–407.

    Article  CAS  Google Scholar 

  29. Ferrara GB, Bacigalupo A, Lamparelli T, Lanino E, Delfino L, Morabito A et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001; 98: 3150–3155.

    Article  CAS  Google Scholar 

  30. Kawase T, Morishima Y, Matsuo K, Kashiwase K, Inoko H, Saji H et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood 2007; 110: 2235–2241.

    Article  CAS  Google Scholar 

  31. Nowak J, Rogatko-Koros M, Zajko M, Mika-Witkowska R, Graczyk-Pol E, Sak-Budzisz J . Wpływ substytucji aminokwasu w pozycji 116 cząsteczki MHC klasy I na wynik transplantacji komórek krwiotwórczych—krytyczna analiza. Acta Haematol Pol 2007; 38 (Suppl 2): 84–85 (abstract 048).

    Google Scholar 

  32. Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521–1526.

    Article  CAS  Google Scholar 

  33. Giebel S, Locatelli FW, Lamparelli T, Velardi A, Davies S, Frumento G et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814–819.

    Article  CAS  Google Scholar 

  34. Petersdorf EW, Gooley T, Horowitz M . Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietifc cell transplantation from unrelated donors. Tissue Antigens 2007; 69 (Suppl 1): 25–30.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Immunogenetics, Institute of Haematology and Transfusion Medicine, Warsaw, Poland

    J Nowak

Authors
  1. J Nowak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Nowak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nowak, J. Role of HLA in hematopoietic SCT. Bone Marrow Transplant 42 (Suppl 2), S71–S76 (2008). https://doi.org/10.1038/bmt.2008.288

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.288

Keywords

This article is cited by

Search

Advanced search

Quick links